You are here
Antibody Prophylaxis and Therapy of Flavivirus Infection
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AI060217-01
Agency Tracking Number: AI060217
Amount:
$969,452.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
L2 DIAGNOSTICS, LLC
BOX 8175
NEW HAVEN, CT
94904
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: RAYMOND Koski
Phone: (203) 589-2029
Email: RAYMOND.KOSKI@L2DX.COM
Phone: (203) 589-2029
Email: RAYMOND.KOSKI@L2DX.COM
Business Contact
Name: MARTIN MATTESSICH
Phone: (203) 737-1952
Email: MJMATT@IX.NETCOM.COM
Phone: (203) 737-1952
Email: MJMATT@IX.NETCOM.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The overall goal of this project is to develop antibody therapy and prophylaxis to treat and prevent life-threatening flavivirus infections. West Nile virus is the focus of Phase I studies. Our working hypothesis is t
* Information listed above is at the time of submission. *
